Evidence map›Paper›PMID 38671145›Full record

ArticlePediatric radiology2024

Bone marrow disease in rhabdomyosarcoma visualized by 2-[

Pia Kröning, Sebastian Berg, Martin T Freitag, Reineke A Schoot, Alexandra Fischer, Alexander Puzik, T Feuchtinger, Charlotte Niemeyer, Philipp Tobias Meyer, Markus Uhl and 1 more

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Pia KröningDivision of General Pediatrics, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Sebastian BergDivision of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Martin T FreitagDepartment of Nuclear Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Reineke A SchootPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Alexandra FischerDivision of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Alexander PuzikDivision of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
T FeuchtingerDivision of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Charlotte NiemeyerDivision of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Philipp Tobias MeyerDepartment of Nuclear Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Markus UhlDivision of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Simone HettmerDivision of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany. simone.hettmer@uk-halle.de.ORCID 0000-0003-1709-4448
University of Freiburg · DEPrincess Máxima Center · NLUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow metastases-noted in 6% of patients with rhabdomyosarcoma-have been linked to very poor outcomes. Bilateral bone marrow sampling from iliac crests has been the gold standard for bone marrow examination in rhabdomyosarcoma, but sampling errors due to patchy bone marrow involvement may limit its sensitivity. Here, we report the case of a 6-year-old boy with embryonal rhabdomyosarcoma of the skull base and multiple 2-[

Indexed as

Bone Marrow NeoplasmsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyRadiopharmaceuticalsChildHumansMaleRhabdomyosarcomaFluorodeoxyglucose F18RadiopharmaceuticalsBone marrow metastasesFlurodeoxyglucose F18PediatricsPositron emission tomography computed tomographyRhabdomyosarcoma

Identifiers

PMID38671145
PMCPMC11255067
OpenAlexW4395677235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.